Insulin secretion is coupled with changes in β-cell metabolism. To define this process, 195 putative metabolites, mitochondrial respiration, NADP + , NADPH and insulin secretion were measured within 15 min of stimulation of clonal INS-1 832/13 β-cells with glucose. Rapid responses in the major metabolic pathways of glucose occurred, involving several previously suggested metabolic coupling factors. The complexity of metabolite changes observed disagreed with the concept of one single metabolite controlling insulin secretion. The complex alterations in metabolite levels suggest that a coupling signal should reflect large parts of the β-cell metabolic response. This was fulfilled by the NADPH/NADP + ratio, which was elevated (8-fold; P < 0.01) at 6 min after glucose stimulation.
INTRODUCTION
Pancreatic β-cells continuously monitor the blood glucose level. After a meal, they secrete insulin in response to a rise in the blood glucose level. This triggers the disposal of absorbed glucose into peripheral tissues. These processes are perturbed in T2D (Type 2 diabetes), leading to hyperglycaemia. In the β-cell, complex mechanisms of stimulus-secretion coupling link the blood glucose level, via intracellular metabolic and signalling events, to exocytosis of insulin. GSIS (glucose-stimulated insulin secretion) is provoked by the combined actions of a triggering pathway (K ATP -dependent) and an amplifying pathway (K ATPindependent) [1, 2] . The triggering pathway involves influx of glucose, subsequent fuel metabolism and ultimately a rise in the cytosolic ATP/ADP ratio. ATP and ADP are known to bind to SUR1 (sulfonylurea receptor 1), a regulatory part of the K ATP channel, closing and opening Kir6.2 respectively [3] . This leads to depolarization of the plasma membrane, opening of voltage-gated Ca 2 + channels and a rise in cytosolic Ca 2 + concentrations. Finally, the elevation of Ca 2 + levels results, through a series of events, in docking of the insulin granules to the plasma membrane and release of insulin [4] . The amplifying pathway involves processes in addition to the closure of the K ATP channel, but still requires an elevation of intracellular Ca 2 + [5] . It serves to increase and sustain the response to glucose. Several coupling factors accounting for the amplifying pathway have been suggested. These include nucleotide ratios, i.e. ATP/ADP [6] and GTP/GDP [7] , NADPH [8] , NADH [9] , CoA-esters of fatty acids (malonyl-CoA and long-chain acyl-CoA) [10] and amino acids, e.g. glutamate [11] . However, their precise contributions and mode of actions remain unresolved, which is reflected by several subsequent studies that have produced conflicting results [12] [13] [14] [15] .
The levels of these suggested metabolic coupling factors are likely to be determined by the tight interplay between glycolysis and the TCA (tricarboxylic acid) cycle, through the decarboxylation/carboxylation of pyruvate and mitochondrial shuttling systems. Involvement of transaminases in the shuttling systems would further affect amino acid metabolism and ultimately the urea cycle. Moreover, interactions between fatty acid metabolism, glycolysis and the TCA cycle have also been implicated in this regulation [10] . Given this complexity, analysing the processes occurring in the cellular metabolic network in a univariate fashion is likely to be insufficient to provide a full understanding of stimulus-secretion coupling in β-cells. Importantly, information about the regulation of metabolites, which are off-target with respect to the hypothesis, is generally lost.
A metabolomics approach allows a deeper understanding of metabolism. The goal of metabolomics is an unbiased and global determination of all metabolites in a biological sample [16] . Compared with traditional approaches, where a single or a few metabolites are measured at a time, metabolomics techniques are capable of measuring hundreds of metabolites simultaneously. More importantly, owing to the richness of the data obtained, an a priori hypothesis about which metabolite(s) might be involved in a given process is not required. Instead, novel hypotheses are potentially generated by the approach.
In the present study, a metabolomics approach was used to examine stimulus-secretion coupling in a clonal insulinomaderived β-cell, the INS-1 832/13 line [17, 18] , and in rat islets. To this end, GC-MS-based metabolomics was applied to investigate the changes in the β-cell metabolome following glucose stimulation [19] . Metabolites in the β-cell were profiled at different time points after glucose stimulation in conjunction with analysis of insulin secretion, mitochondrial respiration, the level of the reducing equivalent NADPH and GSH (reduced glutathione). To aid the visualization and interpretation of the results, multivariate statistics and regression modelling (chemometrics) were applied [20] . OPLS (orthogonal projections to latent structure) [21] was applied to focus the analysis of the metabolomics data on alterations in metabolite levels correlated with insulin secretion. The goal of these studies was to generate information on the dynamics of both metabolism and insulin secretion. More specifically, the aim of the investigation was to identify potential coupling factors in β-cell stimulus-secretion coupling.
EXPERIMENTAL

Internal standards and chemicals
Methoxyamine hydrochloride, N-methyl-N-trimethylsilyl trifluoroacetamide and DHEA (trans-dehydroepiandrosterone) were from Aldrich. Pyridine, heptane, methanol, methyl stearate, alkane standard mixtures (C 8 -C 20 and C 21 -C 40 ) and 6-AN (6-aminonicotinamide) were from Fluka. Isotope-labelled internal standards [ 13 4 ]octanoic acid were from Isotec/Sigma-Aldrich. Water was purified using a Purelab Ultra (Elga). All other reagents and solutions were obtained from Sigma-Aldrich unless otherwise stated. Stock solutions of DHEA (100 mM) and 6-AN (100 mM) were prepared in DMSO.
Cell culture and islet isolation
Clonal β-cells (INS-1 832/13) [17] were grown to 90 % confluency in 5 cm tissue culture dishes in RPMI 1640 containing 11.1 mM glucose and supplemented with 10 % fetal bovine serum, 100 units/ml penicillin, 100 μg/ml streptomycin, 10 mM Hepes, 2 mM glutamine, 1 mM sodium pyruvate and 50 μM 2-mercaptoethanol, at 37
• C in a humidified atmosphere containing 95 % air and 5 % CO 2 . The cells were pre-incubated in Hepesbalanced salt solution [4 ml of Hepes buffer, 114 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.16 mM MgSO 4 , 20 mM Hepes, 2.5 mM CaCl 2 , 25.5 mM NaHCO 3 and 0.2 % BSA (pH 7.2)] containing 2.8 mM glucose for 2 h followed by a stimulatory rise in glucose to 16.7 mM. In experiments with the glucose-6-phosphate dehydrogenase inhibitor DHEA, an additional 30 min pre-incubation with 100 μM DHEA or 0.01 % DMSO as control was employed. Stimulation was subsequently performed using Hepes buffer supplemented with 16.7 mM glucose and 100 μM DHEA or 0.01 % DMSO.
Islets were isolated from male Wistar rats after collagenase digestion, hand-picked under a stereo microscope, and allowed to recover overnight in RPMI 1640 containing 11.1 mM glucose, supplemented with 10 % fetal bovine serum, 100 units/ml penicillin and 100 μg/ml streptomycin, at 37
• C in a humidified atmosphere containing 95 % air and 5 % CO 2 . For metabolomics analysis, each sample comprised 240 islets, which were incubated in 4 ml of Hepes buffer supplemented with 2.8 mM glucose for 1 h followed by a stimulatory rise in glucose to 16.7 mM for the indicated time. All animal experiments were approved by the local Animal Ethics Committee.
Sample preparation
The cells were swiftly washed with 4 ml of ice-cold PBS. Metabolism was subsequently quenched by the addition of 400 μl of methanol at − 80
• C to the cell cultures at 0, 15 and 30 min in the pilot study or at 0, 3, 6, 10 and 15 min after stimulation in the detailed study. The cells were scraped off and sonicated for 4 s at 2 kHz (Sonopuls UW 2070) and 350 μl was transferred to an extraction tube preloaded with stable isotope-labelled internal standards. To this tube 88 μl of water was added, and the tubes were vortex-mixed (VX-2500 Multi Tube Vortexer) for 10 min followed by centrifugation at 17 530 g and 4
• C for 10 min and transfer of 350 μl of supernatant to a GC vial. The samples were evaporated (miVac Duo concentrator) and 20 μl of 20 mg/ml methoxyamine hydrochloride in dry pyridine was added followed by vortex-mixing for 5 min and incubation at room temperature (21
• C) for 17 h. Finally, 20 μl of N-methyl-N-trimethylsilyl trifluoroacetamide was added and the samples were vortex-mixed for 5 min and incubated at 37
• C for 30 min. From each of the 100 samples, 4 μl were mixed and aliquots were placed into 11 vials. These vials are from now on referred to as the QC (quality control) samples.
The islets were treated similarly to the INS-1 832/13-cells with some minor modifications of the protocol. The washing step was omitted for the islets. Instead, islets were centrifuged at 7000 g at 4
• C for 30 s at 0, 6 and 15 min after glucose stimulation. Subsequently, the supernatant was discarded and 300 μl of methanol/water (80:20, v/v), containing the internal standards, were added to quench metabolism. Islets were frozen at − 80
• C before extraction. A 250 μl extract was transferred to GC vials, evaporated and derivatized with 15 μl of 20 mg/ml methoxyamine hydrochloride in dry pyridine for 17 h followed by 30 min incubation with 15 μl of N-methyl-N-trimethylsilyl trifluoroacetamide.
GC-MS
GC/MS was performed on an Agilent 6890N gas chromatograph coupled with a Leco Pegasus III TOFMS electron impact timeof-flight mass spectrometer. Samples of 1 μl were injected in splitless mode using an Agilent 7683B autosampler. The injector temperature was set at 270
• C with a purge time of 115 s. Chromatography was performed on a 30 m × 0.25 mm internal diameter DB5-MS column with a phase thickness of 0.25 μm (J&W Scientific). The temperature programme started isothermally at 70
• C for 5 min, followed by a temperature ramp of 15
• C/min to 310 • C where it was held for 3 min. The transfer line and ion source were both maintained at 250
• C. The ionization energy was set to 70 eV and the data acquisition rate was 20 Hz with a scanning range of 50-800 m/z. Data were acquired using Leco ChromaTOF. Retention indices were calculated from the retention times obtained from the injection of a homologous series of n-alkanes (C 8 -C 40 ). All samples were analysed in a randomized order. The repeatability of the method was on average 22 % RSD with 30 % of detected peaks having an RSD (relative standard deviation) of <10 %, as calculated from the analyses of the QC samples.
Data handling and multivariate statistics
Raw data files were exported from ChromaTOF as NetCDF files to MATLAB 7.0 (MathWorks) for smoothing, alignment and deconvolution, using HMCR (hierarchal multivariate curve resolution) [22] . Peak identification was performed using NIST MS search 2.0, employing the NIST mass spectra library, a library developed at the Max Planck Institute in Golm (available at http://gmd.mpimp-golm.mpg.de/download/), and libraries developed at Umeå Plant Science Centre and in-house at Lund University Diabetes Centre. The QC samples were used to select the appropriate normalization for each of the detected peaks. Thus the scores from either a PCA (principal component analysis) model calculated in SIMCA P + 12.0 (Umetrics AB) on the non-centred and UV (unit variance) scaled peak areas for the internal standards [23] or a single internal standard peak area was applied in accordance with a previously published method [24] . Internal standards and artefact peaks identified from extracted blank samples were removed before modelling. Finally, the normalized peak areas were exported to SIMCA P + 12.0 and all variables were mean-centred, UV-scaled and transformed as described previously [24] . PCA was used to obtain an overview of the data and OPLS was used to relate the metabolic alterations to the time after stimulation. To validate the models, 7-fold crossvalidation of each model was used.
Insulin secretion
Insulin secretion from clonal cells was determined by either static incubation or perifusion as previously described [25, 26] . In brief, ∼ 3 × 10 6 cells were placed in each of four chambers perifused at a flow rate of 1 ml/min. The cells were first perifused for 10 min with buffer containing 2.8 mM glucose. At t = 0 min, glucose was raised to 16.7 mM and samples were collected at 2-min intervals. Insulin was measured by RIA using a charcoal separation method [27] .
INS-1 832/13 cells were cultured in 24-well plates until they reached 90-95 % confluency. Before the assay, the cells were preincubated in Hepes buffer supplemented with 2.8 mM glucose for 2 h at 37
• C. Subsequently, the cells were subjected to an additional 30 min pre-incubation step including Hepes buffer supplemented with 2.8 mM glucose and 100 μM 6-AN, 100 μM DHEA or 0.01 % DMSO as control. Finally, GSIS was measured after an incubation period of 15 min or 1 h at 2.8 or 16.7 mM glucose in the absence or presence of the inhibitors 6-AN or DHEA or 0.01 % DMSO.
Five rat islets were pre-incubated for 1 h, with DHEA or 0.01 % DMSO included for the last 30 min. Subsequently, islets were incubated in 2.8 or 16.7 mM glucose in the presence of either DHEA or DMSO for 15 min or 1 h. Released insulin was assayed by RIA using the Coat-a-Count kit (Siemens Medical Solutions Diagnostics).
Mitochondrial respiration
The OCR (oxygen consumption rate) was measured using the XF24 extracellular flux analyser (Seahorse Bioscience), as described previously in detail in [18] . Following a pre-incubation at 2.8 mM glucose for 1 h and 50 min, the OCR was assayed at 2.8 mM glucose for 10 min preceding addition of glucose to render a final concentration of either 16.7 mM glucose or 2.8 mM glucose. Thereby the OCR measurements mimicked the static insulin secretion assay. The OCR was acquired at 5-min intervals.
NADPH and NADP
+ measurements
Clonal INS-1 832/13 β-cells were grown to 90 % confluency in 12-well plates. The cells were pre-incubated at 2.8 mM glucose for 2 h followed by a rise to 16.7 mM for 3, 6, 10 and 15 min. After incubation in 16.7 mM glucose, the cells were washed twice with ice-cold PBS and snap frozen in a solid CO 2 /ethanol bath to quench pyridine nucleotide metabolism. After thawing on ice, the ruptured cells were scraped into 100 μl of 40 mM NaOH/5 mM cysteine and sonicated for 10 s. Cell fragments were removed by centrifugation for 5 min at 20 000 g and 4
• C. Each sample was divided into two aliquots of 20 μl, and either 10 μl of 200 mM HCl (assay for NADP + ) or 10 μl of 40 mM NaOH/5 mM cysteine (assay for NADPH) were added. Subsequently, the samples were heated for 15 min at 60
• C followed by centrifugation for 1 min at 16 000 g. NADP + and NADPH standards were treated identically and handled in parallel to the samples. Then, 10 μl of each sample were transferred to a fresh tube and 100 μl of cycling reagent [100 mM imidazole (pH 7.0), 5 mM glucose 6-phosphate, 7.5 mM α-ketoglutarate (2-oxoglutarate), 0.1 mM ADP, 25 mM ammonium acetate, 0.1 % BSA, 1.5 units/ml of Leuconostoc glucose-6-phosphate dehydrogenase and 1.5 units/ml of bovine liver L-glutamic dehydrogenase] was added. After incubation for 3 h at 37
• C, the cycling reaction was stopped by heating the samples to 100
• C for 3 min followed by 10 min centrifugation at 16 000 g. The amount of phosphogluconolactone formed was determined by absorbance measurement at 340 nm after combining 10 μl of each sample with 100 μl of indicator buffer [100 mM imidazole (pH 7.0), 30 mM ammonium acetate, 2 mM MgCl 2 , 0.1 mM EDTA, 300 μM NADP + and 0.5 unit/ml of Saccharomyces cerevisiae 6-phosphogluconic dehydrogenase] in a 96-well UV plate and incubating the mixture at 37
• C for 1 h.
ATP production
INS-1 832/13 cells were grown in 24-well plates and preincubated and stimulated as described for insulin secretion. Subsequently, the incubation medium was removed and cells were snap frozen on solid CO 2 /ethanol at 0 and 15 min after stimulation with 16.7 mM glucose in the presence of DHEA or DMSO. Then, cells were lysed by addition of 100 μl of lysis buffer (Tris/EDTA) and ATP measured with a luciferase-based luminescence assay (BioTherma) according to the manufacturer's instructions. For assay of ATP production in islets, ten islets were incubated as described for insulin secretion and ATP was assayed as described above.
Glutathione measurements
GSH was assayed using the ThiolTracker Violet reagent (Invitrogen). INS-1 832/13 cells were grown to 90 % confluency in black-walled clear bottom 96-well plates. Cells were then incubated as described for insulin secretion, using 100 μl of incubation medium. The dye was dissolved in DMSO (20 mM) and was included for the last 30 min of the pre-incubation and during stimulation to yield a final concentration of (20 μM). Metabolism was inhibited at 0 and 15 min by removing the incubation medium and adding 100 μl of 3% formaldehyde in PBS. Cells were then incubated in the dark at room temperature for 30 min before fluorescence measurements at 404 and 526 nm (excitation and emission respectively).
For assay of GSH in islets, 50 islets were incubated as described above for INS-1 832/13-cells, with the exception that preincubation was performed for 60 min and dye, DHEA and DMSO were included in the last 30 min. Incubation media (100 μl) were left in the wells and formaldehyde was added to yield a final concentration of 3 %.
RESULTS
Dynamics of insulin release in response to elevated glucose
The perifusion experiments performed on the clonal INS-1 832/13 β-cell line allowed us to resolve the phasic secretion of insulin in response to glucose. A peak in insulin secretion, reaching a maximal fold increase of 12.2, was observed at 12 min subsequent to stimulation with 16.7 mM glucose ( Figure 1A ). Secretion then persisted at an elevated level for as long as the glucose stimulus remained. Thus the most vigorous response in insulin secretion to glucose stimulation took place within the first 15 min of glucose stimulation. This information was used to define the time frame for the following detailed analysis of the dynamic metabolic changes underlying control of GSIS.
Mitochondrial respiration in response to elevated glucose
The current paradigm holds that metabolic changes in β-cells trigger and sustain insulin secretion [28] . Mitochondria largely account for β-cell metabolism. Here, oxygen is required for the efficient oxidative phosphorylation of ADP to ATP. As oxidative phosphorylation is the pivotal mitochondrial process, the OCR can be used as an index of overall mitochondrial metabolic activity. To confirm the paradigm of metabolic stimulus-secretion coupling also in the clonal INS-1 832/13 β-cells, we examined oxygen consumption in brief intervals (5 min) following a rise in glucose from 2.8 to 16.7 mM. Indeed, cellular oxygen consumption ( Figure 1B ) increased by 30 % (P < 0.01) at 15 min and 40 % (P < 0.001) at 30 min after the rise in glucose. The increase in OCR initially paralleled the rise in insulin secretion, i.e. the greatest increase was observed within 15 min of glucose stimulation. This confirms that mitochondrial activity paralleled GSIS in clonal INS-1 832/13 β-cells.
Identifying time frames of metabolic regulation
Parallel to the assessment of insulin secretion and OCR, a metabolomics analysis was performed to obtain information about the time frame of metabolic regulation essential for GSIS. In this examination, 218 putative metabolite derivatives were detected, of which 53 were identified by the use of databases, including an in-house database. Multivariate analyses were then used to detect glucose-provoked alterations in levels of the detected metabolites. Hence, from these data, a matrix 'X' was generated with each column representing a putatively identified metabolite (expressed as the normalized peak area) and each row representing a sample. In addition to the 'X'-matrix, a 'Y'-vector containing information on the time point of quenching was also created. In a traditional representation of the analysed samples, 218 dimensions would be required (one for each metabolite). In the present study, reduction of the dimensionality greatly facilitated visualization and interpretation of the data set.
To investigate alterations in the metabolite pattern provoked by glucose stimulation, OPLS, a multivariate regression method, was applied [21] . Hereby, the number of data dimensions was reduced and noise, i.e. random changes originating from biological or technical variation, was discarded. Furthermore, variation in the data related to the investigated sample property, i.e. the time of quenching, was isolated from other variation unrelated to this property. Thus metabolic alterations provoked by glucose stimulation could be described in only one dimension, the predictive component (t [1] ), instead of in the original 218 dimensions from which the data were derived. Other systematic variations in the data unrelated to the quenching time were described in the orthogonal components (t o ). The risk of obscuring induced biological variations with variations of another nature is lower in OPLS compared with, e.g. PCA and PLS (partial least squares) regression. Figure S1 at http://www.biochemj. org/bj/450/bj4500595add.htm). Models calculated between 0 and 15 min and between 15 and 30 min revealed that 20 and 6 % respectively of the variation in the metabolome was related to the time of quenching in these intervals. Mainly levels of glycolytic and TCA cycle intermediates were increased, whereas levels of most amino acids were decreased (Supplementary Figure  S1 ). Thus the most profound metabolic alterations paralleled the rise of insulin secretion to its peak at ∼ 12 min after stimulation with 16.7 mM glucose as well as the activation of mitochondrial metabolism reflected by an increase in OCR during the first 15 min. For these reasons, a detailed metabolomics analysis in clonal INS-1 832/13 β-cells with higher time resolution of the metabolite changes was restricted to the first 15 min subsequent to glucose stimulation. The multivariate characterization is described in detail in the Supplementary Online Data at http://www.biochemj.org/bj/450/bj4500595add.htm and only a summary is given in the main text.
In-depth analysis of glucose-stimulated metabolic alterations underlying insulin secretion
Profiling of the metabolome within 15 min of glucose stimulation yielded data on levels of 195 putative metabolite derivatives, of which 61 metabolite derivatives could be identified. These data were subsequently combined in a matrix 'X' and correlated to a vector 'Y' containing the time of quenching.
The OPLS score plot ( Acon, aconitate; AKGA, α-ketoglutarate; Arach, arachidate; BAla2, β-alanine; C4SOH, four carbon sugar alcohol; C5SOH, five carbon sugar alcohol; Cit, citrate; DiHAP, dihydroxyacetone phosphate; Fum, fumarate; Glucp, glucopyranose; Gly2P, glycerol 2-phosphate; Gly3P, glycerol 3-phosphate; Glya2P, 2-phosphoglycerate; Glya3P, 3-phosphoglycerate; IsoMalt, isomaltose; Lac, lactate; Mal, malate; Malt, maltose; OctA, octadecanoate; OHPro, hydroxyproline; OleA, oleate; PalA, palmitate; PEP, phosphoenol pyruvate; PGlu, pyroglutamate; Put, putrescine; SteaA, stearate; Succ, succinate; Tau, taurine; TetA, tetradecanoate.
thus described metabolic alterations provoked by glucose stimulation.
To reveal the metabolic alterations underlying the separation of the samples observed in the score plot (Figure 2A ), the OPLS loading plot for the predictive component (p [1] ) was examined ( Figure 2B ). The loading plot describes how the original coordinate system, i.e. the co-ordinate system constructed from the 195 putative metabolites, relates to the new and reduced coordinate system. The size and the direction of the bars in the loading plot indicate the influence each individual metabolite level has exerted on the separation of the samples in the score plot. In addition, the variation in the metabolite levels in Figure 2 (B) is shown as jack-knifed confidence intervals [29] . In this representation, levels of metabolites with large positive values were increased, and levels of metabolites with large negative values were decreased in response to glucose stimulation. Since the metabolite data were UV-scaled, the loading plots were based only on the variation in the metabolite level and not to the amount of metabolite [30] . The rationale for using UV-scaling is that relative changes in metabolite levels rather than absolute levels may exert a stronger influence on signalling processes.
In accordance with the initial metabolomics analysis, the differences between the samples were mainly driven by pronounced increases in the levels of glycolytic and TCA cycle intermediates ( Figure 2B ). Levels of some amino acids such as proline, aspartate, hydroxyproline, leucine/isoleucine, valine and serine were decreased, whereas levels of cysteine, glycine, glutamate, alanine and pyroglutamate were increased.
After having assessed the overall changes occurring in cellular metabolism after glucose stimulation, we set out to resolve, in more detail, the dynamic changes of metabolite levels for 15 min after stimulation with 16.7 mM glucose. To achieve enhanced time resolution, correlations from OPLS models calculated in different time intervals were plotted against each other in onset-decay plots (Supplementary Tables  S1, S2 and S3, and Supplementary Figure S4 at http://www. biochemj.org/bj/450/bj4500595add.htm). This procedure allowed us to distinguish metabolites that were continuously increased or decreased from those that displayed variable regulation (e.g. possessing an apex or a nadir during the study time interval). It also revealed the rate of change in the levels of the metabolites. These plots showed that glycolytic intermediates increased rapidly and that TCA cycle intermediates displayed a more complex regulation. The combined levels of leucine and isoleucine decreased rapidly in contrast with other amino acids that were more uniformly regulated. Most interestingly, levels of ribose 5-phosphate were increased already at 6 min after glucose stimulation.
To validate the performance of the OPLS models, the abundance of metabolite levels derived from the size of the peak areas in the analysis were also analysed with univariate statistics (Figures 3 and 4A) . Overall, the levels of glycolytic intermediates increased rapidly, reaching a 1.5-3.1-fold elevation (P < 0.01) at 3 min after glucose stimulation. In contrast, the TCA cycle intermediates displayed a more complex regulation. The level of citrate exhibited a rapid increase (3.1-fold at 3 min, P < 0.001), but this was not translated to aconitate (1.2-fold at 3 min, P < 0.05), the subsequent metabolite in the TCA cycle. The difference in the rate of change of the levels of TCA cycle intermediates became even more pronounced for α-ketoglutarate and succinate. Both metabolites exhibited a delayed increase followed by a rapid increase. α-Ketoglutarate was elevated 2.5-fold at 15 min (P < 0.001) and succinate 1.3-fold at both 10 (P < 0.05) and 15 (P < 0.01) min. The delayed onset in levels of α-ketoglutarate was confirmed by stimulating INS-1 832/13 cells with [U-
13 C]-labelled glucose (Supplementary Figure  S5 at http://www.biochemj.org/bj/450/bj4500595add.htm). This allowed us to follow glucose-derived carbons being relocated to α-ketoglutarate. A robust increase in α-ketoglutarate levels could be observed after a 1 h of stimulation with 16.7 mM glucose (Supplementary Figure S6 at http://www.biochemj.org/ bj/450/bj4500595add.htm). The levels of fumarate and malate were more consistently enhanced, reaching a 3.5-fold (P < 0.001) and 5.4-fold (P < 0.001) elevation at 15 min. Among the amino acids, the combined level of leucine/isoleucine showed a very rapid decrease (50 % at 3 min, P < 0.001), whereas the other amino acids were more uniformly regulated.
Most interestingly, the level of ribose 5-phosphate was found to increase rapidly in the first 6 min (2.5-fold, P < 0.001). 
The pentose phosphate pathway: NADPH and ribose 5-phosphate
The reducing equivalent NADPH has been implicated in metabolic stimulus-secretion coupling [31, 32] and is an integrating factor in the complex metabolic response in the β-cell. Therefore we analysed the dynamic changes in the NADPH and NADP + levels occurring during the same time interval in which we analysed metabolic intermediates in detail. We found that the NADPH/NADP + ratio changed significantly in response to an elevation of glucose from 2.8 to 16.7 mM ( Figure 4A) . Interestingly, the changes in the NADPH/NADP + ratio paralleled the level of the pentose phosphate pathway intermediate ribose 5-phosphate ( Figure 4A ). This suggests that the β-cell pentose phosphate pathway responded to glucose stimulation and that it produced NADPH.
Profiling of the pentose phosphate pathway in rat islets
Given that the metabolic analyses were performed on clonal β-cells, which are transformed cells, metabolic features may be different from those seen in primary β-cells. Therefore a targeted metabolite profiling of rat islets was conducted to from triplicate experiments on islets from eight rats. Statistical significance was determined using ANOVA with Bonferroni's. post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.
confirm that the pentose phosphate pathway responds to glucose stimulation also in rat islets. Indeed, this analysis revealed that levels of ribose 5-phosphate were elevated 1.6-fold (P < 0.05) at 15 min after glucose stimulation ( Figure 4B ). Overall, metabolic regulation was similar between the clonal INS-1 832/13 β-cells and the rat islets (Supplementary Figure S7 at http://www. biochemj.org/bj/450/bj4500595add.htm). Levels of glycolytic and TCA cycle intermediates generally increased very rapidly after glucose stimulation. The delayed up-regulation in levels of succinate and α-ketoglutarate observed in the clonal INS-1 832/13 β-cells was observed also in the rat islets. Levels of glutamate increased and those of aspartate decreased after glucose stimulation.
Inhibition of the pentose phosphate pathway
To further investigate the role of the pentose phosphate pathway in GSIS, we inhibited the two key enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconic acid dehydrogenase using DHEA and 6-AN respectively. Although both inhibitors will prevent the synthesis of ribose 5-phosphate, DHEA will abolish formation of NADPH in the pentose phosphate pathway, whereas 6-AN will only partially block formation of NADPH. Notably, GSIS was significantly suppressed in the presence of the glucose-6-phosphate dehydrogenase inhibitor DHEA when assayed after 15 min (P < 0.05) ( Figure 5A ). Importantly, the NADPH/(NADPH + NADP + ) ratio was decreased by 29 % at 15 min in the presence of DHEA (P < 0.01). However, inhibition of 6-phosphogluconic acid dehydrogenase by 6-AN was without effect on GSIS (Supplementary Figure S8A at http://www.biochemj.org/bj/450/bj4500595add.htm). GSIS was still suppressed by 41 % (P < 0.001) after 1 h in the presence of DHEA (Figure 5B ), whereas 6-AN again did not affect GSIS (Supplementary Figure S8B) . A similar response to DHEA was . (E and F) Measurements of ATP production confirmed that DHEA suppresses insulin secretion in both INS-1 832/13 cells (E), and rat islets (F) without affecting levels of ATP. The data are expressed as means + − S.E.M. for four (A, B, E and F) and three (C and D) independent experiments normalized to basal secretion at 2.8 mM glucose. Statistical significance was evaluated using ANOVA followed by Bonferroni's post hoc test. *P < 0.05; **P < 0.01. observed in rat islets, with markedly reduced insulin secretion at 15 min (P < 0.05) ( Figure 5C ) and a 57 % reduction (P < 0.05) ( Figure 5D ) of insulin secretion at 1 h after glucose stimulation.
Insulin secretion is triggered by an increased production of ATP, elevating the ATP/ADP ratio. To investigate whether the inhibitor affected ATP production, ATP production at 0 and 15 min after glucose stimulation in the presence and absence of DHEA was measured. Glucose provoked ATP production in both clonal INS-1 832/13 β-cells and rat islets; this production was unaffected by DHEA ( Figures 5E and 5F ) If the pentose phosphate pathway and ribose 5-phosphate are to play a role in GSIS, inhibition of secretion should be paralleled by an attenuation of the rise of the metabolite on glucose stimulation. To test this hypothesis, the consequences of glucose-6-phosphate dehydrogenase inhibition by DHEA were assessed by a targeted metabolite profiling at 0, 6 and 15 min after glucose stimulation in clonal INS-1 832/13 β-cells. The results of this analysis were plotted in a SUS (shared and unique structures)-like plot ( Figure 6 ). In this plot, glucose-stimulated metabolic regulation in the DHEA-treated cells and in the control cells are shown on the abscissa and the ordinate respectively. INS-1 832/13 cells were stimulated with 16.7 mM glucose in the presence and absence of the glucose-6-phosphate dehydrogenase inhibitor DHEA and the metabolite pattern was measured at 0, 6 and 15 min. From the data generated, an SUS-like plot was generated. This plot shows on the abscissa and ordinate the glucose-provoked metabolic regulation in INS-1 832/13 cells in the presence and absence of DHEA. Thus levels of metabolites to the left and right in the plot decreased and increased respectively, with glucose stimulation in DHEA treated cells. Similarly, metabolites on the top and bottom of the plot increased and decreased respectively, with glucose stimulation in untreated cells. Metabolic regulation identical in the two groups is thereby found on a diagonal from the lower left to the upper right of this plot. Metabolites close to the abscissa are unregulated in control cells and those close to the ordinate are unregulated in DHEA-treated cells. Ribose 5-phosphate, found close to the ordinate, is only up-regulated in the control cells. Glucose 6-phosphate, found close to the abscissa is only up-regulated in the DHEA-treated cells. The inset shows alterations in ribose 5-phosphate levels at 0 (black bar), 6 (white bar) and 15 (grey bar) min after glucose stimulation in the presence and absence of DHEA. The data in the inset are presented as means + − S.E.M. for four independent experiments. Statistical significance was determined using ANOVA with Bonferroni's post hoc test. ***P < 0.001.
Thus, if metabolic regulation were similar under these different conditions, all metabolites would be found on a diagonal crossing the origin of this plot. Indeed, most metabolites did cluster along this diagonal. Notably, ribose 5-phosphate was an exception to this shared regulation. Instead, it was found to be elevated after glucose stimulation only in the control condition. The decline in the level of ribose 5-phosphate at 15 min after stimulation with 16.7 mM glucose observed in our first set of experiments could not be verified. Instead, levels plateaued at 6 min after glucose stimulation. Glucose-provoked production of ribose 5-phosphate was confirmed in an experiment in which INS-1 832/13 cells were stimulated with 16.7 mM [U- 13 C]glucose (Supplementary Figure S5) . Stimulation with glucose for 1 h resulted in a robust increase in levels of ribose 5-phosphate (Supplementary Figure   Figure 7 GSH levels are reduced when the pentose phosphate pathway is inhibited GSH levels measured in INS-1 832/13 cells (A) and rat islets (B) in the presence or absence of the glucose-6-phosphate dehydrogenase inhibitor DHEA. Data are presented as means + − S.E.M. for 18 and eight independent experiments in (A) and (B) respectively. Statistical significance was determined using ANOVA with Bonferroni's post hoc test; 0 compared with 15 min, *P < 0.05; control compared with DHEA, #P < 0.05. S6). In contrast, inhibition of glucose-6-phosphate dehydrogenase by DHEA decreased the levels of ribose 5-phosphate by 58 % (P < 0.001) and 76 % (P < 0.001) at 6 and 15 min after glucose stimulation respectively (inset, Figure 6 ). Conversely, glucose 6-phosphate, the metabolite just proximal to the enzymatic inhibition, was elevated in the DHEA-treated cells: at 15 min after glucose stimulation, glucose 6-phosphate was elevated 1.7-fold (P < 0.05) in the DHEA-treated cells compared with the control condition. Univariate data for all detected metabolites are given in Supplementary Table S4 at http://www.biochemj. org/bj/450/bj4500595add.htm.
Glucose-stimulated GSH production
So far, we have shown that NADPH production in the pentose phosphate pathway is essential for robust insulin secretion. To further link these processes to actual secretion of insulin, we investigated whether manipulation of the pentose phosphate pathway would modulate GSH levels. GSH has been implicated as a modulator of exocytosis in the β-cell [33] , potentially linking metabolism, NADPH and redox levels with exocytosis. Glucose increased GSH levels in both clonal INS-1 832/13 β-cells (1.5-fold, P < 0.05) and rat islets (2-fold, P < 0.05) (Figure 7) . Accordingly, DHEA, the inhibitor of the pentose phosphate pathway, significantly suppressed the effect of glucose to elevate GSH levels both in clonal INS-1 832/13 β-cells and rat islets (Figure 7 ).
DISCUSSION
For decades, metabolic β-cell research has strived to identify a single metabolic coupling factor and/or pathway that link the glucose stimulus to increased exocytosis of insulin. The overarching impression provided by the present metabolomics analysis is that no single metabolite or metabolic pathway linked to glucose metabolism predominates on glucose stimulation. Although some promising candidates have been proposed, one could argue that the only coupling factor that has received robust experimental support so far is the ATP/ADP ratio. It reflects the major metabolic and energetic response of the β-cell to glucose. We reason that any additional metabolite-or pathwaybased metabolic coupling factor would need to fulfil analogous criteria. One such factor that reflects a broader metabolic response is the redox potential of the β-cell.
The NADH/NAD + ratio is one marker for the cellular redox state and metabolic activity. Importantly, it is strictly compartmentalized. In the cytosol, a low NADH/NAD + ratio is required to maintain the high glycolytic rates that are critical for β-cells. In contrast, a high mitochondrial NADH/NAD + ratio is essential for oxidative phosphorylation and consequently ATP production. For these reasons, the NADH/NAD + ratio is unlikely to serve as a direct coupling factor [31] . Notwithstanding, NADH compartmentalization and the associated metabolic coupling between the cytosol and mitochondria replenishing cytosolic NAD + and mitochondrial NADH are crucial for GSIS [18] . In the present study, the levels of glycerol 3-phosphate and lactate increased after glucose stimulation, indicating that the glycerol phosphate shuttle and LDH (lactate dehydrogenase) [34] are actively contributing to cytosolic NAD + replenishment. We further observed time-dependent changes in levels of metabolites such as malate, aspartate, glutamate, α-ketoglutarate and citrate that correlated with previously observed glucose-dependent alterations [11, 13, 14, 35] . These metabolites are involved in metabolite shuttles, including the malate-aspartate and malatecitrate shuttles, which ensure metabolic coupling between the cytosol and mitochondria. Thus the present data imply a tight metabolic coupling and rapid and synchronized activity of metabolite transporters. Notably, they do not support the notion that any single acting metabolic coupling factor emanates from these antiporters, as suggested previously [11, 13, 14, [36] [37] [38] .
Another marker for the cellular redox state is the NADPH/NADP + ratio [8] . Several metabolic pathways potentially contribute to the formation of cytosolic NADPH in β-cells after glucose stimulation. The NADPH/NADP + ratio has been suggested previously to play an important role in β-cell stimulus-secretion coupling via the redox protein glutaredoxin [31, 33] . Recently, Li et al. [39] showed that NOX (NADPH oxidase) 2 knockout increases insulin secretion both in vivo and in vitro [39] . It can be speculated that the deletion of NOX2, the main NOX in islets, could increase NADPH levels during glucose stimulation. NADPH could also be involved in NO production, which was found recently to modify exocytotic proteins and potentiate insulin secretion [40] . The present data further support the notion that a rise in the NADPH/NADP + ratio couples the glucose stimulus with secretion in the β-cell.
Indeed, cytosolic NADPH-forming enzyme reactions associated with pyruvate cycling have received a lot of attention due to a high level of expression of PC (pyruvate carboxylase) in the β-cell [13, 41] . The anaplerotic action of PC is balanced by cataplerosis that may occur via the pyruvate-malate, the pyruvatecitrate or the pyruvate-isocitrate cycles [42] . Observations of reduced expression of PC in islets from patients with T2D as well as in islets from animal models of T2D support a central role of PC in β-cell function [43, 44] . Moreover, knockdown of NADP + -dependent malic enzyme in clonal β-cells suppresses GSIS [45] [46] [47] , but this could not be replicated in primary rat islets [47] . The abrogation of the NADPH-generating activity of the cytosolic isocitrate dehydrogenase, which is fuelled by mitochondrial citrate and converts isocitrate into α-ketoglutarate re-entering the mitochondria, also impairs GSIS [32] . However, this action in β-cell stimulus-secretion coupling has not yet been reconciled with the fact that the isocitrate dehydrogenase may be inhibited by ATP [48] .
In the present study, we could show that NADPH is also produced from the pentose phosphate pathway. The extent of pentose phosphate pathway activity in islets has been debated over the years [41, [49] [50] [51] [52] . Notwithstanding, it has been suggested that amplification of GSIS by the gut hormone cholecystokinin involves increased pentose phosphate pathway activity [53] . Moreover, reduced pentose phosphate pathway activity reduces GSIS in islets from old animals [54] , and its perturbation has been implicated in glucotoxicity [55, 56] . Indeed, patients with glucose-6-phosphate dehydrogenase deficiency exhibit impaired insulin secretion [57] . Along such lines, the present study identified alterations in the level of ribose 5-phosphate that paralleled alterations in the NADPH/NADP + ratio. In two previous studies, inhibition of 6-phosphogluconic acid dehydrogenase with 6-AN was shown to suppress GSIS in vivo in rats [58] and in clonal INS-1E β-cells [56] . In the clonal cells, this inhibition caused accumulation of pentose phosphate pathway intermediates [56] . In the present study, our data indicate that 6-AN does not exert an acute effect on GSIS. This discrepancy can be explained by the more chronic exposure, i.e. 6 h for the rats and 48 h for the INS-1E β-cells, to 6-AN in previous studies. Furthermore, inhibition of 6-phosphogluconic acid dehydrogenase with 6-AN only partially inhibits production of NADPH in the pentose phosphate pathway; NADPH is also produced in the preceding step catalysed by glucose-6-phosphate dehydrogenase. Recently, a 25 % reduction in GSIS was observed in human islets in which 6-phosphogluconic acid dehydrogenase was knocked down using small interfering RNAs [56] . The present results showed that the glucose-6-phosphate dehydrogenase inhibitor DHEA, which inhibits the pentose phosphate pathway upstream of NADPH production, decreased GSIS by 41 % in INS-1 832/13 β-cells and by 57 % in isolated rat islets. Laychock and Bauer [59] applied DHEA during culture of both islets and RINm5F clonal β-cells, and showed that when the inhibitor was also present during stimulation, both glucose-6-phosphate dehydrogenase activity and insulin secretion were decreased. Removal of DHEA during stimulation reversed its effects, thus suggesting that the effect is acute. Additionally, we could show that this inhibitor, besides being an acute modulator of pentose phosphate pathway activity, was also selective for the pentose phosphate pathway in this time frame. In the present study, we observed reduced levels of ribose 5-phosphate and increased accumulation of the pentose phosphate pathway substrate glucose 6-phosphate, indicating that glucose flux through this pathway was decreased. Importantly, we could also show that the inhibitor did not affect ATP production, indicating that the triggering signal for GSIS was intact.
After having established a role of the pentose phosphate pathway in NADPH production and modulation of GSIS, we set out to investigate a potential link to the exocytotic machinery. GSH has been implicated as a modulator of the exocytotic machinery as a co-factor of glutaredoxin [33] . GSH is synthesized from cysteine, glutamate and glycine, and reduced by NADPH. Glucose has been shown previously to induce NADPH production from the pentose phosphate pathway and to increase GSH levels; the activity of the pentose phosphate pathway and insulin secretion could be modulated by addition of exogenous insulin [60] . In the present study, we tried to establish a link between glucose stimulation, pentose phosphate pathway activity and GSH levels. Indeed, we found that GSH was significantly decreased in both clonal INS-1 832/13 β-cells and rat islets after incubation with DHEA. A role of GSH in GSIS is further supported by several studies suggesting the involvement of glutamate in β-cell stimulus-secretion coupling [2, 11] . Depleting the culture medium of the glutamate precursor glutamine or cysteine residues decreases GSH levels in neurons [61] . Furthermore, it was shown recently that GSIS from β-cells is higher in culture medium than in simple salt buffers, suggesting that the medium supplies metabolic intermediates enhancing insulin secretion [62] .
Recently, Rebelato et al. [63] confirmed that the pentose phosphate pathway is active in the β-cell; inhibition of the pathway by DHEA blunted insulin secretion and decreased the suppression of ROS (reactive oxygen species) production provoked by glucose. However, the influence of acute glucose stimulation on ROS production remains controversial [63, 64] . Rebelato et al. [63] suggested that increased ROS production drives an altered redox state to which addition of ROS scavengers partially restores GSIS. However, increased ROS production would also increase GSH oxidation, thereby reducing GSH levels. Furthermore, decreased ROS levels induced by addition of ROS scavengers, as performed by Rebelato et al. [63] , would indirectly increase levels of reduced GSH. The present data instead suggest that GSH levels depend on pentose phosphate pathway activity. Of note, GSH has been suggested to be tightly linked to the secretory machinery [33] .
In the present study, where our aim was to investigate the acute metabolic response in β-cells to glucose stimulation, and subsequently the response of the pentose phosphate pathway, we were hesitant to silence glucose-6-phosphate dehydrogenase using RNA interference. Previously, glucose-6-phosphate dehydrogenase was knocked out in mice, islets and clonal β-cells, which resulted in increased ROS production, decreased insulin secretion, increased apoptosis and decreased proliferation [65] . These results may rather reflect a glucotoxic response of β-cells, and therefore be attributed to a chronic reduction in redox capacity and production of ribose units for biosynthesis of, e.g., nucleotides. These circumstances may also explain why significant damage to the β-cells was observed.
In conclusion, the present data suggest that the pentose phosphate pathway is involved in the acute redox response to glucose stimulation. The data are consistent with a model where NADPH generated in the pentose phosphate pathway increases cellular levels of GSH, which may act directly on the exocytotic machinery. An important aspect of this pathway in the β-cell is that, in the absence of key gluconeogenetic enzymes, it is confined to glucose metabolism. Furthermore, the pathway is connected to glycolysis downstream of glucokinase, an integral part of the β-cell glucose sensing machinery. Moreover, it does not seem to interfere with production of ATP, a critical coupling factor in GSIS. For these reasons, glucose sensing and control of GSIS by a signal originating from or depending on the pentose phosphate pathway is feasible. The level of GSH, mediated via the NADPH/NADP + ratio, is a cellular signal that may complement the ATP/ADP ratio in β-cell stimulus-secretion coupling. Figure S1B ) again showed a greater difference between samples quenched at 0 and 15 min, compared with those quenched at 15 and 30 min. The loading plot showed that mainly amino acid levels are decreasing, whereas levels of glycolytic and TCA cycle intermediates increased ( Figure S1C ). Abbreviations used in the loading plots are shown in Table S1 .
THE METABOLIC RESPONSE TO GLUCOSE STIMULATION
Next, the metabolic alterations taking place within 15 min of glucose stimulation were investigated in detail by measuring the metabolome at 0, 3, 6, 10 and 15 min after glucose stimulation. A PCA model was calculated to give an overview of the data. The model required 11 components and had an explained variation of 79 % (R 2 X = 0.789) and a predictive power of 61 % (Q 2 X = 0.605). The first component was found to mainly describe the variation related to the analytical run-order ( Figure S2A ), whereas the second component mainly described variation related to the time after glucose stimulation ( Figure S2B ). No outliers were observed in the data.
Next, an OPLS model was calculated with the time of quenching as Y-variable. It was found that 12 % of the variation in the metabolome could be related to the time after stimulation Figure S3 . Next, models were calculated to highlight differences in onset and decay of alterations in metabolite levels ( Figure S4A ). Six OPLS models were calculated (Table S2 ) and combined according to Table S3 and Figure S4 (A) with the time of quenching as Yvariable. The onset-decay plots generated ( Figures S4B and S4C) clearly indicate that the onset or decay of metabolic regulation differed substantially, also within the same metabolic pathway. For instance, levels of α-ketoglutarate and succinate had a late onset. Changes in the other TCA cycle intermediates detected tended to have a faster onset. Leucine and isoleucine had a very fast decay in the first 3 min, followed by no alterations in the subsequent 12 min. Hydroxyproline also had a very fast decay, only slightly slower than leucine/isoleucine. Other amino acids, such as serine and valine, had much slower decays.
METABOLOMICS ON RAT ISLETS
A targeted metabolite profiling was performed on primary rat islets. An OPLS model was calculated to compare the metabolite profile at basal and at 15 min after glucose stimulation. The model required one predictive and three orthogonal components and explained 37 % (R Figure S7 (B). Aspartate and some other amino acids were decreased, whereas glycolytic and TCA cycle intermediates and a number of fatty acids were increased after glucose stimulation.
INHIBITION OF THE PENTOSE PHOSPHATE PATHWAY
Two inhibitors selective for pentose phosphate pathway enzymes were added acutely to INS-1 832/13 β-cells and GSIS measured after 15 min and 1 h. The 6-phosphogluconic acid dehydrogenase inhibitor 6-AN did not alter GSIS when administered acutely ( Figure S8 ). 13 C]glucose. Clearly, α-ketoglutarate exhibits a delayed onset with a major increase in its level occurring after 6-15 min. At 15 min α-ketoglutarate levels were increased 3.6-fold. In the detailed metabolomics study, α-ketoglutarate levels reached a 2.5-fold increase after 15 min. Thus levels of α-ketoglutarate increased 3.3-fold between 15 min and 1 h. Ribose 5-phosphate levels increased 3-fold at 15 min. In the detailed metabolomics analysis, ribose 5-phosphate levels increased 2.5-fold 6 min after glucose stimulation. In the later experiments ribose 5-phosphate levels reached a 5-fold increase 15 min after stimulation. Thus ribose 5-phosphate levels reached its maximal level already at 15 min after glucose stimulation. Statistical analysis was performed using regression analysis on six independent experiments; P values are given in the Figure. (A) Six OPLS models were calculated for different time-intervals within 15 min of stimulation with 16.7 mM glucose. These models will each reveal whether a metabolite increases, decreases or remains unchanged within this time interval. By combining these plots at the borders indicated as broken lines, metabolites possessing non-linear alterations such as apexes and nadirs can be identified (B). Plotting the correlations of these models against each other reveals the shape of the curve describing the alteration in the metabolite level. In these plots, metabolite levels being continuously increased (1), continuously decreased (2), possessing a transient elevation 
